Supply Chain

Maryland lawmakers want to eliminate a "gag rule" that forbids pharmacists from sharing better deals on prescription drugs with patients, reports the Washington Examiner.

Cerebrotech Medical Systems on Jan. 4 earned FDA clearance for the Cerebrotech Visor, a diagnostic device for patients undergoing neurological assessment.

Here are six drug and medical device companies that made headlines in the past week.

Caring Voice Coalition, one of the largest patient assistance charities in the nation, will not offer financial aid this year, reports Reuters.

During Alex Azar's tenure in multiple leadership roles at Eli Lilly, the drug company extended the patent for Cialis by testing the best-selling erectile dysfunction drug on children, according to Politico.

Pfizer will end research into treatments for Alzheimer's and Parkinson's disease, resulting in the elimination of 300 positions at the company's Massachusetts facilities in Andover and Cambridge, and its Connecticut facility in Groton, reports The Wall Street Journal.

U.S. biopharmaceutical firm Celgene will acquire Impact Biomedicines, a San Diego-based startup focusing on developing treatments for complex cancers, for up to $7 billion, according to Reuters.

Medical device industry group AdvaMed on Friday launched a television ad campaign, urging Congress to kill the ACA's device tax, which took effect Jan. 1 after a two-year suspension, according to The Wall Street Journal.

Amgen on Friday earned expanded FDA approval for its drug Xgeva, reports Reuters.

The FDA expects IV fluid shortages to improve early this year after a leading manufacturer of IV saline bags — Baxter International — announced all of its facilities in Puerto Rico have returned to the commercial power grid.